Current Ratio of Serina Therapeutics, Inc. from 31 Mar 2020 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Serina Therapeutics, Inc. quarterly Current Ratio in % history and change rate from 31 Mar 2020 to 30 Sep 2025.
  • Serina Therapeutics, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 181%, a 144% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Serina Therapeutics, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 181% +107% +144% 30 Sep 2025
Q2 2025 114% +29% +34% 30 Jun 2025
Q1 2025 83% +39% +89% 31 Mar 2025
Q4 2024 68% +45% +196% 31 Dec 2024
Q3 2024 74% +63% +569% 30 Sep 2024
Q2 2024 85% +75% +732% 30 Jun 2024
Q1 2024 44% +30% +213% 31 Mar 2024
Q4 2023 23% +4% +21% 31 Dec 2023
Q3 2023 11% -8% -41% 30 Sep 2023
Q2 2023 10% -11% -51% 30 Jun 2023
Q1 2023 14% -9% -39% 31 Mar 2023
Q4 2022 19% -11% -37% 31 Dec 2022
Q3 2022 19% -16% -46% 30 Sep 2022
Q2 2022 21% -20% -49% 30 Jun 2022
Q1 2022 23% -22% -49% 31 Mar 2022
Q4 2021 30% -11% -27% 31 Dec 2021
Q3 2021 35% -20% -36% 30 Sep 2021
Q2 2021 41% -38% -48% 30 Jun 2021
Q1 2021 45% -77% -63% 31 Mar 2021
Q4 2020 41% 31 Dec 2020
Q3 2020 55% 30 Sep 2020
Q2 2020 79% 30 Jun 2020
Q1 2020 122% 31 Mar 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.